Determining the Effectiveness of Remote Monitoring of Cancer Patients With Oral Cancer Treatment Using Caaring® Software

Launched by PERSEI VIVARIUM · May 21, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a software called Caaring® is for monitoring cancer patients who are receiving treatment at home. The main goal is to see if this remote monitoring tool helps patients manage their care better and reduces the need for in-person or phone visits with doctors and nurses. Participants in the trial will be divided into two groups: one group will use the Caaring® platform for their follow-up care, while the other group will continue with their usual medical visits.

To be eligible for this trial, patients must be at least 18 years old and currently receiving outpatient oral cancer treatments, like certain medications used for cancer therapy. They should also feel comfortable using a smartphone, as the Caaring® software requires some basic technological skills. Participants will be monitored over a 12-week period, and they can expect to share their experiences and feedback through the software. This trial is currently recruiting patients, and it aims to empower individuals in their cancer journey by providing more tools for self-management.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who provide informed consent.
• • Age ≥18 years.
• • Oncology patients undergoing active outpatient oral therapy with: capecitabine, cyclin inhibitors, hormonal therapies, TKI inhibitors, monotherapy with or without intravenous therapy.
• • Oncology patients undergoing active outpatient oral oncology treatment expected within 12 weeks of inclusion.
• • Patients who must demonstrate sufficient technological skills to operate a smartphone through the "technological skills questionnaire."
• • Patients who do not meet the exclusion criteria.
• Exclusion Criteria:
• • Patients with cognitive or sensory difficulties or insufficient command of Spanish language that, in the opinion of the healthcare professional conducting the recruitment, makes it difficult to understand the questions posed in the surveys, scales, or instruments used in the study, provided they do not have a legal representative capable of participating in the study.
• • Patients for whom it is anticipated that follow-up will not be possible due to a change of residence.
• • Patients who are participating in any other clinical trial or experimental study at the time of recruitment. Participation in observational studies will not be an exclusion criteria.
• • Patients whose primary diagnosis is a mental illness or another poorly controlled medical condition.
• • Terminally ill patients and/or those receiving palliative care according to the criteria of SECPAL (Spanish Society of Palliative Care).
• • Institutionalized patients.
• • Patients who, according to the recruiting professional's assessment, are not considered eligible for inclusion because they are undergoing specific follow-up care in other units (hemodialysis, transplants, etc.) requiring mandatory hospital visits less frequently than once every two months.
• • Patients who do not demonstrate sufficient technological skills to use a smartphone through the "technological skills questionnaire."